Alzheimer’s Disease/Dementia News

Kirtan Kriya, a form of yoga meditation, improved cognitive function and may protect women against the development of Alzheimer’s disease, according to a presentation at the Alzheimer’s Association International Conference.

Patients with mild-to-moderate-Alzheimer’s disease receiving monotherapy with acetylcholinesterase inhibitors reported cognitive and physical improvements compared with those receiving a combination of memantine and acetylcholinesterase inhibitors, according to a meta-analysis presented at the Alzheimer’s Association International Conference. 

Different foods provided benefits associated with dementia, Alzheimer’s disease and cognition, according to several abstracts presented at the Alzheimer’s Association International Conference.

Reduced levels of plasmalogens synthesized in the liver may adversely affect central nervous system synaptic and antioxidant functions, potentially contributing to cognitive decline in patients with Alzheimer’s disease, according to study results released at the Alzheimer’s Association International Conference 2018.

Bryostatin, a compound that showed an ability to induce synaptogenesis and prevent neuronal death in pretrials, now shows potential as a modifier of Alzheimer’s disease in patients who were memantine-naive, according to data presented at the Alzheimer’s Association International Conference.

Middle-aged adults who experience a sudden drop in BP when standing up, known as orthostatic hypotension, may have a greater risk for dementia or having an ischemic stroke, according to research published in Neurology.

In a large cohort of French older adults, study findings revealed that blood glucose level was the only cardiometabolic factor with consistently elevated mean levels among patients with dementia compared with controls up to 14 years before diagnosis.

Nabilone — a synthetic cannabinoid — reduced agitation and improved neuropsychiatric symptoms, cognition and nutrition in patients with moderate-to-severe Alzheimer’s disease, according to research presented at the 2018 Alzheimer's Association International Conference.

Patients at increased risk for CVD but without diabetes, who were treated to a systolic BP target of 120 mm Hg or less had significantly less risk for mild cognitive impairment as well as white matter lesion volume vs. their counterparts treated to a systolic BP of 140 mm Hg or less according to two separate abstracts presented at the Alzheimer’s Association International Conference.

Older men who napped for 120 minutes or more per day were significantly more likely to develop dementia than those who napped for shorter durations, according to a presentation at the Alzheimer’s Association International Conference.